Show simple item record

dc.contributor.advisorMackay-Sim, Alan
dc.contributor.advisorMeedeniya, Adrian
dc.contributor.authorNorazit, Anwaren_US
dc.date.accessioned2018-01-23T02:28:32Z
dc.date.available2018-01-23T02:28:32Z
dc.date.issued2011en_US
dc.identifier.doi10.25904/1912/2026
dc.identifier.urihttp://hdl.handle.net/10072/366312
dc.description.abstractParkinson’s disease is a progressive neurodegenerative disorder, characterised histopathologically by the degenerating nigrostriatal pathway. Previous studies have shown a decrease in neurogenesis, dopaminergic neurons and neurotrophic factor levels in the Parkinson brain. This thesis investigates the capability of vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) to stimulate endogenous neurogenesis and offer direct or indirect neuroprotection in a novel model of Parkinson’s disease. To assess the neurogenic capability of the postnatal substantia nigra, the effect of age and nigrostriatal circuitry function was examined. Animals were randomised into 2 cohorts; one cohort the control while the other received a partial unilateral 6-hydroxydopamine (6-OHDA; 4 μg) lesion. All animals received 10 day exposure to 5-ethynyl-2′-deoxyuridine (EdU; 25 mg/kg body weight) after lesion to label proliferative cells. An increase in age decreased neurogenic potential of the substantia nigra and dentate gyrus of rats. A partial lesion increased cell proliferation; with the change showing an interaction between age and treatment. The current data shows the highest neurogenic potential at day 28 after weaning, with a near complete lack of neurogenesis at 2 years. With increasing age, a decrease in neurotrophic factors has been reported. The current data supports the hypothesis for neurotrophic factors influencing endogenous neurogenesis. A novel Parkinson’s disease rat model that mimics human pathophysiology using a low dose rotenone induced intra-medial forebrain bundle lesion was developed. Rotenone is a highaffinity inhibitor of complex 1 of the mitochondrial electron transport chain. Complex 1 inhibition by rotenone causes the production of reactive oxygen species that result in oxidative damage of the dopaminergic neurons. The animal model demonstrated a glial response together with a slow degenerative change (cell stress; oxidative stress; α-synuclein production; cell death) similar to human Parkinson’s disease. This is a useful model for testing therapeutic interventions, including neuroprotective and neurogenic agents for Parkinson’s disease.en_US
dc.languageEnglishen_US
dc.publisherGriffith Universityen_US
dc.publisher.placeBrisbaneen_US
dc.rights.copyrightThe author owns the copyright in this thesis, unless stated otherwise.en_US
dc.subject.keywordsParkinson's deiseaseen_US
dc.subject.keywordsNeurodegenerative disorderen_US
dc.subject.keywordsVascular endothelial growth factor (VEGF)en_US
dc.subject.keywordsPlatelet derived growth factor (PDGF)en_US
dc.titleVascular Endothelial Growth Factor (VEGF) and Platelet Derived Growth Factor (PDGF) in a Novel Model of Parkinson's Diseaseen_US
dc.typeGriffith thesisen_US
gro.facultyScience, Environment, Engineering and Technologyen_US
gro.description.notepublicPublished articles, and conference papers included in Appendices have not been published here.en_US
gro.rights.copyrightThe author owns the copyright in this thesis, unless stated otherwise.
gro.hasfulltextFull Text
dc.rights.accessRightsPublicen_US
gro.identifier.gurtIDgu1342502079516en_US
gro.source.ADTshelfnoADT0en_US
gro.source.GURTshelfnoGURT1256en_US
gro.thesis.degreelevelThesis (PhD Doctorate)en_US
gro.thesis.degreeprogramDoctor of Philosophy (PhD)en_US
gro.departmentSchool of Biomolecular and Physical Sciencesen_US
gro.griffith.authorNorazit, Anwar


Files in this item

This item appears in the following Collection(s)

Show simple item record